SCHEMBL919372

SCHEMBL919372

CNCCC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17919936 1.00 SIGMAR1 (0.50)
Hydrochloric Acid SCHEMBL14744246 0.97
SCHEMBL21675740 0.89 SIGMAR1 (0.43)
SCHEMBL17919937 0.89 SIGMAR1 (0.48)
SCHEMBL25927003 0.89 CARM1 (0.45)
SCHEMBL1680312 0.88
SCHEMBL919693 0.88
SCHEMBL22330605 0.87 SIGMAR1 (0.42)
SCHEMBL13792717 0.87 SIGMAR1 (0.42)
SCHEMBL21675732 0.87 SIGMAR1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023147513-A2 COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2023-08-03 WO claimed
US-20200157382-A1 SLURRY COMPOSITION FOR POLISHING TUNGSTEN BARRIER LAYER KCTECH CO.,LTD. (KR) 2020-05-21 US claimed
EP-3495439-A1 SLURRY COMPOSITION FOR POLISHING TUNGSTEN BARRIER LAYER KCTECH CO., LTD. (KR) 2019-06-12 EP claimed
CN-109563375-A Tungsten barrier polishing slurry composition 凯斯科技股份有限公司 2019-04-02 CN claimed
US-20070299081-A1 Heterocyclic Derivatives and Their Use as Mediators of Stearoyl-Coa Desaturase XENON PHARMACEUTICALS INC. (CA) 2007-12-27 US claimed
EP-1799668-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDIATORS OF STEAROYL-COA DESATURASE XENON PHARMACEUTICALS INC. (CA) 2007-06-27 EP claimed
WO-2006034338-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS MEDIATORS OF STEAROYL-COA DESATURASE XENON PHARMACEUTICALS INC. (CA) 2006-03-30 WO claimed
US-12617797-B2 Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain ESTEVE PHARMACEUTICALS, S.A. (ES) 2026-05-05 US disclosed
US-20240059690-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2024-02-22 US disclosed
WO-2023147513-A2 COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2023-08-03 WO disclosed
EP-4023694-A1 EPOXY GROUP-CONTAINING POLYORGANOSILOXANE, CURABLE RESIN COMPOSITION CONTAINING EPOXY GROUP-CONTAINING POLYORGANOSILOXANE, AND CURED PRODUCT OF SAME Mitsubishi Chemical Corporation (JP) 2022-07-06 EP disclosed
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-06-23 US disclosed
EP-3885342-A1 BICYCLIC INHIBITORS OF PAD4 Padlock Therapeutics, Inc. (US) 2021-09-29 EP disclosed
WO-2004041829-A1 QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2004-05-21 WO disclosed
US-5864043-A CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST KARL THOMAE GMBH (DE) 1999-01-26 US disclosed
EP-0581677-B1 Cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy JOUVEINAL INST RECH (FR) 1997-01-08 EP disclosed
US-5541229-A ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS DR. KARL THOMAE GMBH (DE) 1996-07-30 US disclosed
US-5326784-A Psychological and gastrointestinal disorders INSTITUT DE RECHERCHE JOUVEINAL (FR) 1994-07-05 US disclosed
EP-0581677-A1 Cycloalkylalkylamines which are sigma-receptor ligands, process for preparing them and their application in therapy INSTITUT DE RECHERCHE JOUVEINAL (I.R.J) (FR) 1994-02-02 EP disclosed
US-4466901-A FROM A PHENOL, AN AMINE AND A SULFUR COMPOUND STANDARD OIL COMPANY (INDIANA) (US) 1984-08-21 US disclosed